ZENLABSDiversified Commercial Services
Zenlabs Ethica Ltd — Cash Flow Statement
₹17.37
+0.00%
Zenlabs Ethica Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 3.81 Cr | -9.08 Cr | -0.03 Cr | -0.41 Cr | — |
| Capital Expenditure | -0.02 Cr | -0.02 Cr | -1.55 Cr | -0.03 Cr | — |
| End Cash Position | 1.79 Cr | 0.91 Cr | 1.62 Cr | 1.51 Cr | — |
| Beginning Cash Position | 0.91 Cr | 1.62 Cr | 1.51 Cr | 1.57 Cr | — |
| Changes In Cash | 0.88 Cr | -0.71 Cr | 0.11 Cr | -0.07 Cr | — |
| Financing Cash Flow | -3.08 Cr | 8.24 Cr | 0.06 Cr | 0.31 Cr | — |
| Interest Paid Cff | -0.74 Cr | -0.55 Cr | -0.15 Cr | -0.06 Cr | — |
| Net Issuance Payments Of Debt | -1.11 Cr | 10.02 Cr | 1.61 Cr | 1.11 Cr | — |
| Net Short Term Debt Issuance | -0.78 Cr | 10.33 Cr | 0.41 Cr | 1.26 Cr | — |
| Net Long Term Debt Issuance | -0.34 Cr | -0.31 Cr | 1.19 Cr | -0.14 Cr | — |
| Investing Cash Flow | 0.14 Cr | 0.11 Cr | -1.47 Cr | 15000.00 | — |
| Interest Received Cfi | 26000.00 | 0.13 Cr | 0.08 Cr | 0.03 Cr | — |
| Net PPE Purchase And Sale | 0.15 Cr | 0.00 | — | 0.00 | 0.06 Cr |
| Sale Of PPE | 0.15 Cr | 0.00 | — | 0.00 | 0.06 Cr |
| Capital Expenditure Reported | -0.02 Cr | -0.02 Cr | -1.55 Cr | -0.03 Cr | — |
| Operating Cash Flow | 3.83 Cr | -9.06 Cr | 1.52 Cr | -0.38 Cr | — |
| Taxes Refund Paid | -0.21 Cr | -0.13 Cr | -0.27 Cr | -0.12 Cr | — |
| Change In Working Capital | 1.34 Cr | -11.62 Cr | -1.17 Cr | -2.66 Cr | — |
| Change In Other Current Liabilities | 0.13 Cr | 0.47 Cr | -0.27 Cr | 0.73 Cr | — |
| Change In Other Current Assets | -1.01 Cr | 0.81 Cr | -0.32 Cr | -0.69 Cr | — |
| Change In Payable | 2.15 Cr | -13.28 Cr | 3.58 Cr | 2.60 Cr | — |
| Change In Inventory | -1.10 Cr | -0.63 Cr | -2.71 Cr | -3.47 Cr | — |
| Change In Receivables | 1.11 Cr | 0.94 Cr | -1.53 Cr | -1.86 Cr | — |
| Other Non Cash Items | 0.92 Cr | 0.78 Cr | 1.03 Cr | 0.29 Cr | — |
| Provisionand Write Offof Assets | 0.09 Cr | 0.05 Cr | 0.00 | — | — |
| Depreciation And Amortization | 1.26 Cr | 1.29 Cr | 1.25 Cr | 0.89 Cr | — |
| Depreciation | 1.26 Cr | 1.29 Cr | 1.25 Cr | 0.89 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -54000.00 | -0.01 Cr | — | — | — |
| Gain Loss On Sale Of PPE | 71000.00 | 0.00 | — | 0.00 | 0.01 Cr |
| Net Income From Continuing Operations | 0.43 Cr | 0.58 Cr | 0.67 Cr | 1.22 Cr | — |
| Net Other Financing Charges | — | 1000.00 | — | — | -10.00 |
| Cash Dividends Paid | — | — | -0.16 Cr | — | — |
| Deferred Tax | — | — | — | 0.00 | 0.09 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | — | — | -1.43 |
| Net Other Investing Changes | — | — | — | — | 1000.00 |
| Purchase Of PPE | — | — | — | — | -0.61 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Zenlabs Ethica Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.